[BCG-treatment of malignant melanoma].
D000917:Antibody Formation; D001500:BCG Vaccine / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*
D001500:BCG Vaccine
Die BCG-Behandlung des malignen Melanoms